Furthermore, TNF antagonists have shown promise as adjunctive therapies to enhance antidepressant efficacy in treatment-resistant depression (144), and patients with MDD may also benefit from corticosteroids and NSAIDs (145). The gene discussed is TNF; the disease is major depressive disorder.